Skip to main content
The Oncology Institute, Inc. (TOI)
NASDAQ: TOI · IEX Real-Time Price · USD
1.150
-0.030 (-2.54%)
At close: Apr 26, 2024, 4:00 PM
1.160
+0.010 (0.87%)
After-hours: Apr 26, 2024, 6:53 PM EDT

The Oncology Institute Revenue

In the year 2023, The Oncology Institute had annual revenue of $324.24M with 28.42% growth. Revenue in the quarter ending December 31, 2023 was $85.79M with 20.11% year-over-year growth.

Revenue (ttm)
$324.24M
Revenue Growth
+28.42%
P/S Ratio
0.26
Revenue / Employee
$405,299
Employees
800
Market Cap
85.46M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023324.24M71.76M28.42%
Dec 31, 2022252.48M49.48M24.37%
Dec 31, 2021203.00M15.49M8.26%
Dec 31, 2020187.52M32.11M20.66%
Dec 31, 2019155.41M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
111, Inc. 2.11B
PetMed Express 276.97M
Burning Rock Biotech 75.80M
ProPhase Labs 44.38M
Eton Pharmaceuticals 32.64M
Aclaris Therapeutics 31.25M
HOOKIPA Pharma 20.13M
Gritstone bio 16.34M
Revenue Rankings

TOI News

More News